Cheng May M
Fasken, Martineau, DuMoulin, LLP, Ontario, Canada.
J Diabetes Sci Technol. 2009 Nov 1;3(6):1516-20. doi: 10.1177/193229680900300634.
It is no longer possible to identify counterfeit medical products, including medications and devices, by simply checking packaging and labeling. Improvements in technology have made it cheaper and easier to produce fake packaging and labels, making it nearly impossible for consumers and authorities to detect counterfeits without conducting tests on the products themselves, as illustrated by the sale of over one million counterfeit blood glucose test strips sold to unsuspecting U.S. consumers at drugstores in more than 35 states and in other countries around the world in the fall of 2006. The pricier the drugs, the more counterfeiters seek to mimic them to maximize returns, victimizing those patients at highest risk who rely on life-saving medications.
现在,仅通过检查包装和标签已无法识别假冒医疗产品,包括药品和器械。技术的进步使得生产假冒包装和标签变得更便宜、更容易,这使得消费者和监管机构几乎不可能在不对产品本身进行检测的情况下发现假冒产品,2006年秋季在超过35个州的药店以及世界其他国家向毫无戒心的美国消费者出售了超过100万条假冒血糖测试条就说明了这一点。药品价格越高,造假者就越想模仿它们以实现利润最大化,从而使那些依赖救命药物、风险最高的患者成为受害者。